UNSPSC 51434800: Antihypertensive drugs, synthesized

This classification denotes Antihypertensive drugs composed of multiple constituents, with no dominant constituent.

UNSPSC 51434800 Antihypertensive drugs, synthesized is a Class code encompassing the procurement of blood pressure management medications for emergency medical services, health agencies, and cooperative purchasing programs. State and local governments buy specific antihypertensive formulations—labetalol, diltiazem, and related agents—as part of Advanced Life Support medication supplies for fire rescue operations and broader pharmaceutical benefit programs. Issuing bodies include city fire departments, state health and human services agencies, and multistate cooperative purchasing alliances. The City of Tampa's fire rescue operation and the Texas Health and Human Services Commission represent the primary issuing bodies visible in recent activity, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administers contracts covering participating state and local government facilities across multiple states.

Recent activity spans Florida, Texas, and Minnesota-led cooperative purchasing. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026, seeking 370 units of labetalol HCI 100mg vials and related agents for Tampa Fire Rescue with an estimated contract value of $40,000 and a one-year term with two optional one-year renewals. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling upstream market research that will likely lead to formal procurement. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals distributed across state and local government facilities in Minnesota and Oregon, with contract effectiveness on July 1, 2026. The MMCAP solicitation emphasizes price competitivity (75 percent of evaluation weight), cGMP and DSCSA compliance, and relationships with authorized wholesalers including Cencora, Cardinal Health, and Morris & Dickson.